Patents by Inventor Jason O'Connor

Jason O'Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230277766
    Abstract: Disclosed are techniques to establish a modified pump rate that mitigates the effects of a pump occlusion and enables a recommended dosage of insulin to be output by a pump mechanism over the course of a control cycle. In an example, the pump rate may be reduced by adding a calculated time interval between application of actuation commands to extend the amount of time over which insulin may be output by the pump mechanism.
    Type: Application
    Filed: May 12, 2023
    Publication date: September 7, 2023
    Inventors: Yibin ZHENG, Joon Bok LEE, Jason O'CONNOR
  • Patent number: 11744944
    Abstract: Systems and methods for automatically delivering medication to a user. A sensor coupled to a user can collect information regarding the user. A controller can use the collected information to determine an amount of medication to provide the user. The controller can instruct a drug delivery device to dispense the medication to the user. The drug delivery device can be a wearable insulin pump that is directly coupled to the user. The controller can be part of or implemented in a cellphone. A user can be required to provide a confirmation input to allow a determined amount of insulin to be provided to the user based on detected glucose levels of the user. The sensor, controller, and drug delivery device can communicate wirelessly.
    Type: Grant
    Filed: June 11, 2020
    Date of Patent: September 5, 2023
    Assignee: INSULET CORPORATION
    Inventors: Jason O'Connor, Daniel Allis, David Nazzaro, John R. Bussiere, John D'Arco
  • Patent number: 11738144
    Abstract: Disclosed are techniques and devices that are operable to receive one or a number of generalized parameters of an automated insulin delivery algorithm. An input of at least one generalized parameter corresponding to a user may be used to set one or more of the number of specific parameters of the automated insulin delivery algorithm based on the inputted at least one generalized parameter. Physiological condition data related to the user may be collected. The automated insulin delivery algorithm may determine a dosage of insulin to be delivered based on the collected physiological condition. Signals may be output to cause a liquid drug to be delivered to the user based on an output of the automated insulin delivery algorithm related to the determined dosage of insulin.
    Type: Grant
    Filed: September 26, 2022
    Date of Patent: August 29, 2023
    Assignee: INSULET CORPORATION
    Inventors: Joon Bok Lee, Bonnie Dumais, Jason O'Connor, Yibin Zheng
  • Publication number: 20230256167
    Abstract: Disclosed are techniques to establish initial settings for an automatic insulin delivery device. An adjusted total daily insulin (TDI) factor usable to calculate a TDI dosage may be determined. The adjusted TDI factor may be a TDI per unit of a physical characteristic of the user (e.g., weight) times a reduction factor. The adjusted TDI factor may be compared to a maximum algorithm delivery threshold. Based on the comparison result, the application or algorithm may set a TDI dosage and output a control signal. Blood glucose measurement values may be collected from a sensor over a period of time. A level of glycated hemoglobin of the blood may be determined based on the obtained blood glucose measurement values. In response to the level of glycated hemoglobin, the set TDI dosage may be modified. A subsequent control signal including the modified TDI dosage may be output to actuate delivery of insulin.
    Type: Application
    Filed: March 20, 2023
    Publication date: August 17, 2023
    Inventors: Joon Bok LEE, Mengdi LI, Jason O'CONNOR, Yibin ZHENG
  • Publication number: 20230248909
    Abstract: Disclosed are processes and techniques for a correction factor determination process for determining a correction factor for delivering a drug to a patient via a drug delivery device. For example, for an insulin delivery device, the disclosed techniques enable adjustment of the patient’s correction factor in real time based on the deviation of the patient’s glucose concentrations against clinically recommended targets. For example, a method for determining a correction factor may include determining an insulin action (Iaction) for a patient over a duration, the insulin action representing a total insulin metabolized, determining glucose information for the patient over the duration, the glucose information representing glucose activity, and determining an estimated correction factor (CFest) based on (glucose information) / (insulin action) for the duration. Other embodiments are described.
    Type: Application
    Filed: February 6, 2023
    Publication date: August 10, 2023
    Inventors: Joon Bok LEE, James GRAHAM, Jason O'CONNOR, Yibin ZHENG
  • Publication number: 20230233650
    Abstract: Ucn2 derivatives comprising a peptide and a substituent with high potency, high physical and high chemical stability, suitable for administration to humans, and their medical use in treatment and/or prevention of obesity and/or diabetes.
    Type: Application
    Filed: July 15, 2022
    Publication date: July 27, 2023
    Inventors: Chien Li, Nicholas Raymond Cox, Jason O'Neil, Patrick William Garibay, Berit Christoffersen Gyrstinge, Hans Dennis Aasberg, Lennart Lykke, Nikolaj Kulahin Roed
  • Publication number: 20230233765
    Abstract: A wearable drug delivery device, techniques, and computer-readable media that provide an application that implements a diabetes treatment plan for a user are described. The drug delivery device may include a controller operable to direct operation of the wearable drug delivery device. The controller may provide a selectable activity mode of operation for the user. Operation of the drug delivery device in the activity mode of operation may reduce a likelihood of hypoglycemia during times of increased insulin sensitivity for the user and may reduce a likelihood of hyperglycemia during times of increased insulin requirements for the user. The activity mode of operation may be manually activated by the user or may be activated automatically by the controller. The controller may automatically activate the activity mode of operation based on a detected activity level of the user and/or a detected location of the user.
    Type: Application
    Filed: March 27, 2023
    Publication date: July 27, 2023
    Inventors: Jason O’CONNOR, Joon Bok LEE, Trang LY, Todd VIENNEAU, Yibin ZHENG, Ashutosh ZADE
  • Publication number: 20230233764
    Abstract: Disclosed are a computing apparatus, a computer-readable medium and a method that enable a user to use subjective inputs to alter settings of a wearable automatic drug delivery system. A user input device is presented on a graphical user interface that enables input of a subjective insulin need parameter. In response to receiving the input, the processor may modify a subjective coefficient value. A specific factor useable by an automatic insulin delivery algorithm is set based on the subjective coefficient value. Physiological condition data related to the user and the set specific factor may be used to determine a dosage of insulin to be delivered to the user based on the collected physiological condition data of the user. The processor may cause the determined dosage of insulin to be delivered to the user based on an output of the automatic insulin delivery algorithm.
    Type: Application
    Filed: January 20, 2023
    Publication date: July 27, 2023
    Inventors: Joon Bok LEE, Jason O'CONNOR, Yibin ZHENG, Graeme NELSON
  • Publication number: 20230233762
    Abstract: Exemplary embodiments may provide a user interface and logic for assisting a user in calculating a proper medicament bolus dosage. The user interface may be simple and easy to understand. The user interface may clearly specify needed inputs, such as a carbohydrates amount for a meal that is about to be ingested and the current glucose level reading for the user. Entered inputs may be displayed on the user interface. The user interface may depict key calculated values resulting from calculations that involve the inputs, including the total bolus dosage calculation. The user interface also may depict the values that contribute to the total bolus dosage calculation. Some of the input values, such as carbohydrates amount, may be prepopulated by the management device or medicament delivery device. The user interface may permit overriding of prepopulated input values.
    Type: Application
    Filed: January 19, 2023
    Publication date: July 27, 2023
    Inventors: Joon Bok LEE, Yibin ZHENG, Jason O'CONNOR, Kerrie GALLAGHER, Lindsay PHILBRICK, Alex NGUYEN, Joshua WILLIAMS
  • Publication number: 20230230668
    Abstract: Disclosed herein are systems and methods for providing safeguards, in an automatic drug delivery system, to prevent or compensate for insufficient delivery of bolus doses of a liquid drug. The safeguards include, for example, features built into the medication delivery algorithm to allow the medication delivery algorithm to ensure that proper bolus doses are delivered, either manually by the user or automatically by the drug delivery system. In addition, various methods are described for providing the medication delivery algorithm with a means for determining when a meal has been ingested and, in some embodiments, for providing an automatic bolus dose of the liquid drug in response to the determination.
    Type: Application
    Filed: January 17, 2023
    Publication date: July 20, 2023
    Inventors: Joon Bok LEE, Rangarajan NARAYANASWAMI, Yibin ZHENG, Ashutosh ZADE, Jason O'CONNOR
  • Patent number: 11706894
    Abstract: A cable manager connected to a network rack that routes cables in and around the network rack. The cable manager includes a body with plurality of fingers extending from the body. The distal end of at least one finger includes a hinge pin holder. The cable manager also includes a door hingedly attached to the fingers extending from the body. The door has a front, a back, edges, and at least one hinge pin receptacle positioned along the edges of the door. The hinge pin receptacle houses a magnet to enable the door to attach to the hinge pin holder of the at least one finger to hold the door in a closed position.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: July 18, 2023
    Assignee: Panduit Corp.
    Inventors: Jason O'Young, Kevin M. Zumbek
  • Publication number: 20230218813
    Abstract: Systems and methods for cleansing blood are disclosed herein. The methods include acoustically separating undesirable particles bound to capture particles from formed elements of whole blood. After introducing the capture particles to whole blood containing undesirable particles, the whole blood and capture particles are flowed through a microfluidic separation channel. At least one bulk acoustic transducer is attached to the microfluidic separation channel. A standing acoustic wave, imparted on the channel and its contents by the bulk acoustic transducer, drives the formed elements and undesirable particles bound to capture particles to specific aggregation axes. After aggregating the particles, the formed elements exit the separation channel through a first outlet and are returned to the patient. The undesirable particles, bound to the capture particles, exit through a second outlet and can be discarded to saved for later study.
    Type: Application
    Filed: March 14, 2023
    Publication date: July 13, 2023
    Applicant: The Charles Stark Draper Laboratory, Inc.
    Inventors: Jason O. Fiering, Shivshanker Sundaram, Andrew Meuller
  • Publication number: 20230208112
    Abstract: In one example, a laser assembly may include a substrate, a lens array, and a laser array. The lens array may be positioned on a first side of the substrate. The laser array may be positioned on a second side of the substrate opposite the first side. Lasers of the laser array may be oriented to generate optical signals through the substrate to corresponding lenses of the lens array. The lens array may include at least one concave lens and at least one convex lens. The concave and convex lenses may map the irradiance of the lasers to a common target irradiance profile, resulting in an alignment tolerant laser assembly.
    Type: Application
    Filed: March 1, 2023
    Publication date: June 29, 2023
    Inventor: Jason O'DANIEL
  • Patent number: 11684713
    Abstract: Disclosed is a fluid delivery device including a fluid reservoir and a transcutaneous access tool fluidly coupled to the fluid reservoir, wherein the transcutaneous access tool includes a needle or a trocar. The fluid delivery device may further include a transcutaneous access tool insertion mechanism for deploying the transcutaneous access tool, wherein the insertion mechanism is configured to insert and retract the needle/trocar in a single, uninterrupted motion.
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: June 27, 2023
    Assignee: INSULET CORPORATION
    Inventors: Steven Diianni, Ian McLaughlin, Jason O'Connor, Robert Campbell, Kevin Schmid
  • Patent number: 11684716
    Abstract: Disclosed are techniques to establish a modified pump rate that mitigates the effects of a pump occlusion and enables a recommended dosage of insulin to be output by a pump mechanism over the course of a control cycle. In an example, the pump rate may be reduced by adding a calculated time interval between application of actuation commands to extend the amount of time over which insulin may be output by the pump mechanism.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: June 27, 2023
    Assignee: INSULET CORPORATION
    Inventors: Yibin Zheng, Joon Bok Lee, Jason O'Connor
  • Publication number: 20230181824
    Abstract: Disclosed are a system, methods and computer-readable medium products that provide safety constraints for an insulin-delivery management program. Various examples provide safety constraints for a control algorithm-based drug delivery system that provides automatic delivery of a drug based on sensor input. Glucose measurement values may be received at regular time intervals from a sensor. A processor may predict future glucose values based on prior glucose measurement values. The safety constraints assist in safe operation of the drug delivery system during various operational scenarios. In some examples, predicted future glucose values may be used to implement safety constraints that mitigate under-delivery or over-delivery of the drug while not overly burdening the user of the drug delivery system and without sacrificing performance of the drug delivery system. Other safety constraints are also disclosed.
    Type: Application
    Filed: January 25, 2023
    Publication date: June 15, 2023
    Inventors: Jason O'CONNOR, Joon Bok LEE, Trang LY, Yibin ZHENG, Thomas Arnold PEYSER, Jennifer Lena SCHNEIDER
  • Publication number: 20230173173
    Abstract: A drug delivery device may include an Inertial Measurement Unit (IMU) is provided. The IMU may include an accelerometer, a magnetometer, or a gyroscope. Motion parameters may be detected when the drug delivery device is shipped, being prepared for activation for use, or during use. The IMU may provide data indicative of a rapid deceleration, such as when a package containing the drug delivery device is dropped, or some other physical event experienced by the drug delivery device. The drug delivery device may also include internal or external pressure sensors or a blood glucose sensor that may coordinate with the IMU to provide additional feedback regarding the status of the device or user. A controller of the drug delivery device may generate a response depending on the particular parameters being monitored or may change device operational parameters as a result of detected system events.
    Type: Application
    Filed: January 27, 2023
    Publication date: June 8, 2023
    Inventors: Jason O'CONNOR, Joon Bok LEE, Ian MCLAUGHLIN, John D'ARCO
  • Publication number: 20230166034
    Abstract: Disclosed herein is a method for execution by a drug delivery device for determining an optimal dose of a liquid drug for current cycle of a medication delivery algorithm, the method utilizing a stepwise evaluation of a model and a cost function across a coarse search space consisting of coarse discrete quantities of the drug and a refined search space consisting of refined discrete quantities of the drug.
    Type: Application
    Filed: May 24, 2022
    Publication date: June 1, 2023
    Inventors: Joon Bok LEE, Yibin ZHENG, Jason O'CONNOR, Ashutosh ZADE
  • Patent number: 11628251
    Abstract: A wearable drug delivery device, techniques, and computer-readable media that provide an application that implements a diabetes treatment plan for a user are described. The drug delivery device may include a controller operable to direct operation of the wearable drug delivery device. The controller may provide a selectable activity mode of operation for the user. Operation of the drug delivery device in the activity mode of operation may reduce a likelihood of hypoglycemia during times of increased insulin sensitivity for the user and may reduce a likelihood of hyperglycemia during times of increased insulin requirements for the user. The activity mode of operation may be manually activated by the user or may be activated automatically by the controller. The controller may automatically activate the activity mode of operation based on a detected activity level of the user and/or a detected location of the user.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: April 18, 2023
    Assignee: INSULET CORPORATION
    Inventors: Jason O'Connor, Joon Bok Lee, Trang Ly, Todd Vienneau, Yibin Zheng, Ashutosh Zade
  • Publication number: 20230116691
    Abstract: A shared optic assembly for combined flood and dot illumination modules is disclosed. The shared optic assembly includes a first high-powered VCSEL element for providing a flood beam and a second high-powered VCSEL element for providing a dot beam, where both the first and second VCSEL elements share the same optics and are incorporated onto the same module for space savings.
    Type: Application
    Filed: October 8, 2021
    Publication date: April 13, 2023
    Inventors: Jason O'Daniel, Pei-Song Cai, Francesco Shiattone